首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:International journal of neuropsychopharmacology

缩写:INT J NEUROPSYCHOPH

ISSN:1461-1457

e-ISSN:1469-5111

IF/分区:4.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2186
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Junya Maruoka,Kohei Kozuka,Ryo Egami et al. Junya Maruoka et al.
Introduction: Major depressive disorder (MDD) is frequently accompanied by residual symptoms such as anxiety and sleep disturbances, even after adequate antidepressant treatment. Brexpiprazole, a serotonin-dopamine activi...
Michael Berk,Stephen M Stahl,Lakshmi Yatham et al. Michael Berk et al.
Conventional antidepressant, antipsychotics and mood stabilising drugs share several characteristics. Firstly, they have a slow onset of action with benefits accruing late that is broadly mediated by long term homeostatic processes. Respons...
Huey-Ting Li,Yu Chen,Shefali Chaudhary et al. Huey-Ting Li et al.
Extant research has implicated functional connectivity of the subgenual anterior cingulate cortex (sgACC) in major depressive disorders or depressive traits in neurotypical populations. However, prior studies have not distinguished the inpu...
Mu-Hong Chen,Ying-Jay Liou,Ju-Wei Hsu et al. Mu-Hong Chen et al.
Background: Increasing evidence has suggested a potential role of glymphatic system function in the pathomechanisms underlying mood disorders and related cognitive impairment. However, this association in bipolar disorder...
Laura M Fiori,Corina Nagy,Gustavo Turecki Laura M Fiori
Background: Major depressive disorder (MDD) is a debilitating condition that is commonly treated with antidepressants. However, many people do not respond to treatment, and the molecular mechanisms underlying antidepressa...
Alexander Marsh,Darren Quelch,Marion Mackonochie et al. Alexander Marsh et al.
The incidence of cognitive disorders is rising and medications to address cognitive impairments are limited. Phytochemical compounds have had some success in improving cognitive outcomes in preclinical studies. However, the evidence surroun...
Min-Chiao Chang,Chun-Hsin Chen,Shih-Chun Meng et al. Min-Chiao Chang et al.
Background: Response to naltrexone varies among individuals with alcohol use disorder (AUD). Studies in Western populations have linked the sweet-liking (SL) phenotype, reflecting an individual's hedonic response to sweet...
Xianzhen Zhou,Foroogh Ghorbani,Veit Roessner et al. Xianzhen Zhou et al.
Background: Segmenting continuous experience into discrete units-event segmentation-is fundamental for situational awareness and adaptive action. Based on Event Segmentation Theory (EST), we used auricular transcutaneous ...
Charles R Conway,Augustus John Rush,Scott T Aaronson et al. Charles R Conway et al.
Importance: Greater levels of treatment resistance in major depressive disorder (MDD) are associated with lower rates of initial benefit and higher rates of relapse (lower durability). ...
Ryan E Tyler,Rabea K Pfaff,R M Naseer Khan et al. Ryan E Tyler et al.
Objective: Ghrelin and LEAP2 act via the growth hormone secretagogue receptor (GHSR), which modulates feeding, alcohol use, and endocrine and immune system function. The GHSR blocker PF-5190457 has potential as a novel ph...